SCHEMBL6983303

SCHEMBL6983303

O=C(c1ccc(Br)o1)N1CCC(Nc2ccccc2)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.54
ALDH1A1 P00352 4/20 0.54
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54
PKM P14618 1/20 0.54
TSHR P16473 2/20 0.46
BRD4 O60885 1/20 0.43
BRD2 P25440 1/20 0.43
BRD3 Q15059 1/20 0.43
GFER P55789 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 1/20 0.42
ATM Q13315 1/20 0.42
HTT P42858 2/20 0.41
GAA P10253 2/20 0.41
MAPK10 P53779 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6977257 0.99 LMNA (0.53) LMNAALDH1A1RAB9ANPC1PKM
SCHEMBL6970584 0.82 GFER (0.63) LMNAALDH1A1RAB9ANPC1BRD4
SCHEMBL6972459 0.81 ALDH1A1 (0.61) LMNAALDH1A1RAB9ANPC1PKM
SCHEMBL6972662 0.78 GFER (0.70) LMNABRD4BRD2BRD3GFER
SCHEMBL6972668 0.78 GFER (0.70) LMNABRD4BRD2BRD3GFER
SCHEMBL6972665 0.78 GFER (0.70) LMNABRD4BRD2BRD3GFER
SCHEMBL17503186 0.77 BRD4 (0.65) LMNABRD4BRD2BRD3GFER
SCHEMBL4131021 0.73 P2RY1 (0.66) LMNAALDH1A1RAB9ATSHRBRD4
SCHEMBL4127735 0.71 BRD4 (0.57) LMNAALDH1A1RAB9ANPC1TSHR
SCHEMBL6979289 0.71 SPTLC2 (0.71) ALDH1A1BRD4BRD2BRD3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-11-20 US disclosed
EP-1283055-A1 SOLUBLE BETA AMYLOID PRECURSOR PROTEIN SECRETION PROMOTERS Takeda Chemical Industries, Ltd. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters APP, BDNF, BACE1 LMNA 1185/4885ALDH1A1 1933/4885RAB9A 3558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.